Anne Lesage
Founder chez PHARVARIS N.V.
Fortune : 6 M $ au 31/03/2024
Profil
Anne Lesage is the founder of GrayMatters Consulting BVBA (founded in 2010), Kosa Pharma GmbH (founded in 2013), Pharvaris NV (founded in 2015), and Pharvaris GmbH (founded in 2015).
She holds the title of Chief Early Development Officer at Pharvaris NV and Pharvaris GmbH.
Dr. Lesage earns a doctorate degree from Ghent University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARVARIS N.V.
0,61% | 10/03/2023 | 250 000 ( 0,61% ) | 6 M $ | 31/03/2024 |
Postes actifs de Anne Lesage
| Sociétés | Poste | Début |
|---|---|---|
| PHARVARIS N.V. | Founder | 30/09/2015 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Founder | 01/10/2015 |
Anciens postes connus de Anne Lesage
| Sociétés | Poste | Fin |
|---|---|---|
| Kosa Pharma GmbH | Founder | - |
| GrayMatters Consulting BV | Founder | - |
Formation de Anne Lesage
| Ghent University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| GrayMatters Consulting BV | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Health Technology |
| Kosa Pharma GmbH |
